Maren Bacher
BioNTech (Germany)(DE)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, SARS-CoV-2 detection and testing, Animal Virus Infections Studies, COVID-19 Clinical Research Studies, Bacillus and Francisella bacterial research
Most-Cited Works
- → Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera(2022)383 cited
- → Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche(2020)296 cited
- → Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes(2022)218 cited
- → Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5(2022)74 cited
- → Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice(2022)34 cited
- → Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity(2023)32 cited
- → Neutralization of SARS-CoV-2 Omicron pseudovirus by BNT162b2 vaccine-elicited human sera(2021)24 cited
- → Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes(2022)11 cited
- → Omicron breakthrough infection drives cross-variant neutralization and memory B cell formation(2022)10 cited